Anmeldung erfolgt in Kürze...
Details werden geladen...
Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes | The Manila Times
PHILADELPHIA, July 06, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. ('Context” or the 'Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging ('TCE”) bispecific antibodies for solid tumors, today announced that the Company was added to the small-cap Russell 2000® and the broad-market Russell 3000® Indexes, effective at the close of U.S. equity markets on June 26, 2026.
Ähnliche Seiten
Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes | The Manila Times
https://www.manilatimes.net/2026/06/29/tmt-newswire/globenewswire/sagimet-biosciences-joins-the-russell-2000-and-russell-3000-indexes/2374731Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes | The Manila Times
https://www.manilatimes.net/2026/06/29/tmt-newswire/globenewswire/elicio-therapeutics-added-to-russell-2000-and-russell-3000-indexes/2374800Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes | The Manila Times
https://www.manilatimes.net/2026/06/29/tmt-newswire/globenewswire/relmada-therapeutics-joins-russell-2000-and-russell-3000-indexes/2374730Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes | The Manila Times
https://www.manilatimes.net/2026/06/29/tmt-newswire/globenewswire/orchestra-biomed-joins-russell-3000-and-russell-2000-indexes/2374806Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap® | The Manila Times
https://www.manilatimes.net/2026/06/27/tmt-newswire/globenewswire/ascendis-joins-multiple-russell-us-indexes-including-the-russell-3000-russell-1000-russell-2500-and-russell-midcap/2373967